Calcium Chloride PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
10043-52-4
Molecular formula
CaCl2
Molecular weight
110.98 g/mol
Drug class
Calcium replacement agentintravenous electrolyte and membrane-stabilising salt
Mechanism of action
Provides ionised calcium required for excitation-contraction coupling and neuromuscular transmission. In severe hyperkalaemia, calcium stabilises the cardiac myocyte membrane and reduces immediate arrhythmia risk but does not lower serum potassium.
Indications / reported uses
Treatment of acute symptomatic hypocalcaemia
Cardiac membrane stabilisation in severe hyperkalaemia with electrocardiographic changes, and in selected calcium-channel-blocker toxicity protocols
Calcium replacement in selected emergency settings; route and dose must follow product-specific IV safety instructions
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Calcium Chloride PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Calcium Chloride Permitted Daily Exposure (PDE) report (the Calcium Chloride PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Calcium Chloride Occupational Exposure Limit (OEL) report (the Calcium Chloride OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.